- Our high-throughput approach is fast and cost effective.
- Does not depend on knowledge or assumption of the target protein.
- Simultaneous discovery of multiple biologically relevant targets and antibodies.
- Enables the selection of functionally relevant B cells.
- Maximize the discover of antibodies with potent antitumor activity.
- Rapid ability to translate the findings into a clinically relevant therapy.